An update on dual Src/Abl inhibitors.
Musumeci, Francesca
An update on dual Src/Abl inhibitors. [electronic resource] - Future medicinal chemistry Apr 2012 - 799-822 p. digital
Publication Type: Journal Article; Review
1756-8927
10.4155/fmc.12.29 doi
Aniline Compounds--chemistry
Animals
Antineoplastic Agents--chemistry
Benzodioxoles--chemistry
Dasatinib
Fusion Proteins, bcr-abl--antagonists & inhibitors
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Models, Molecular
Nitriles--chemistry
Protein Kinase Inhibitors--chemistry
Proto-Oncogene Proteins c-abl--antagonists & inhibitors
Pyrimidines--chemistry
Quinazolines--chemistry
Quinolines--chemistry
Thiazoles--chemistry
src-Family Kinases--antagonists & inhibitors
An update on dual Src/Abl inhibitors. [electronic resource] - Future medicinal chemistry Apr 2012 - 799-822 p. digital
Publication Type: Journal Article; Review
1756-8927
10.4155/fmc.12.29 doi
Aniline Compounds--chemistry
Animals
Antineoplastic Agents--chemistry
Benzodioxoles--chemistry
Dasatinib
Fusion Proteins, bcr-abl--antagonists & inhibitors
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Models, Molecular
Nitriles--chemistry
Protein Kinase Inhibitors--chemistry
Proto-Oncogene Proteins c-abl--antagonists & inhibitors
Pyrimidines--chemistry
Quinazolines--chemistry
Quinolines--chemistry
Thiazoles--chemistry
src-Family Kinases--antagonists & inhibitors